Is radical cystectomy mandatory in every patient with variant histology of bladder cancer
Open Access
- 1 April 2011
- journal article
- Published by SAGE Publications in Rare Tumors
- Vol. 3 (2) , 67-70
Abstract
Urothelial carcinomas have an established propensity for divergent differentiation. Most of these variant tumors are muscle invasive but not all. The response of non muscle invasive variant tumors to intravesical immunotherapy with BCG is not established in the literature, and is reported here. Between June 1995 and December 2007, 760 patients (mean age of 67.5 years) underwent transurethral resection of first time bladder tumors in our institution. Histologically variant tumors were found in 79 patients (10.4%). Of these 57 patients (72%) of them had muscle-invasive disease or extensive non-muscle invasive tumors and remaining 22 patients (28%) were treated with BCG immunotherapy. These included 7 patients with squamous differentiation, 4 with glandular, 6 with nested, 4 with micropapillary and 1 patient with sarcomatoid variant. The response of these patients to immunotherapy was compared with that of 144 patients having high-grade conventional urothelial carcinomas. Median follow-up was 46 months. The 2 and 5-year progression (muscle-invasion) free survival rates were 92% and 84.24% for patients with conventional carcinoma compared to 81.06% and 63.16% for patients with variant disease (P=0.02). The 2 and 5-year disease specific survival rates were 97% and 91.43% for patients with conventional carcinoma compared to 94.74 % and 82% for patients with variant disease (P=0.33). 5 patients (22.7%) of variant group and 13 patients (9.03%) of conventional group underwent cystectomy during follow-up (P=0.068). Patients with non-muscle invasive variants of bladder cancers can be managed with intravesical immunotherapy if tumor is not bulky (>4 cm). Although progression to muscle invasive disease is more common than in conventional group and occurs in about 40% of the patients, life expectancy is similar to patients with conventional high-grade urothelial carcinomas provided that follow-up is meticulous.Keywords
This publication has 12 references indexed in Scilit:
- Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implicationsLaboratory Investigation, 2009
- The impact of variant histology on the outcome of bladder cancer treated with curative intentUrologic Oncology: Seminars and Original Investigations, 2009
- Urothelial Carcinoma with Divergent Histologic Differentiation (Mixed Histologic Features) Predicts the Presence of Locally Advanced Bladder Cancer When Detected at Transurethral ResectionUrology, 2007
- Micropapillary bladder cancerCancer, 2007
- The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomyInternational braz j urol, 2007
- Muscle-invasive urothelial cell carcinoma of the human bladder: multidirectional differentiation and ability to metastasizeHuman Pathology, 2007
- Variantes histológicas del carcinoma urotelial con implicaciones diagnósticas, pronósticas y terapéuticasActas Urológicas Españolas, 2007
- The Case for Early Cystectomy in the Treatment of Nonmuscle Invasive Micropapillary Bladder CarcinomaJournal of Urology, 2006
- Local recurrence after radical cystectomy for invasive bladder cancer: An analysis of predictive factorsUrology, 2004
- The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostateCancer, 1993